Researchers discovered that combining two FDA-approved drugs prevents ovulation over the entire fertile window, leading to a potential new option for on-demand birth control.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.